首页|环状RNA CircHIPK3在非小细胞肺癌中的研究进展

环状RNA CircHIPK3在非小细胞肺癌中的研究进展

扫码查看
肺癌是全世界发病率和致死率最高的恶性肿瘤之一,虽然针对肺癌的靶向、免疫治疗等新兴治疗手段取得了显著进展,但如何治愈肺癌仍是一项备受瞩目的话题.其中环状RNA(circular RNA,circRNA)作为最近发现的一类具有共价闭合结构的环状RNA,具有结构稳定、序列保守及疾病特异性表达等特点.当前医学前沿揭示了circRNA的失调与多种癌症的发展过程有关.其中,研究热点之一的环状RNAHIPK3(circular RNA HIPK3,circHIPK3)是一种致癌基因,主要起源于基因HIPK3的第二个外显子.越来越多的证据表明circHIPK3参与了非小细胞肺癌(non-small cell lung cancer,NSCLC)等多种恶性肿瘤的发展,并且circHIPK3的异常表达与NSCLC的疾病机制、诊断、治疗以及预后密切相关.本文旨在对circHIPK3在NSCLC中的最新研究进展进行综述,以推动肺癌的精准诊疗.
Research Progress of Circular RNA CircHIPK3 in Non-small Cell Lung Cancer
Lung cancer ranks among the most prevalent and deadliest malignancies worldwide.Despite significant strides in targeted therapies and immunotherapy for lung cancer,curing the disease remains a highly prioritized issue.Circular RNAs(circRNAs),recently discovered RNA molecules characterized by covalently closed loop structures,possess features such as structural stability,sequence conservation,and disease-specific expression.Cutting-edge medical research has linked circRNA dysregulation to the progression of various cancers.Among these,circular RNA HIPK3(circHIPK3),an oncogenic gene primarily derived from the second exon of the HIPK3 gene,has emerged as a focal point of investigation.Increasing evi-dences suggest that circHIPK3 is involved in the development of non-small cell lung cancer(NSCLC)and other malignancies.Aberrant expression of circHIPK3 is closely associated with the disease mechanisms,diagnosis,treatment,and prognosis of NSCLC.This review discusses the latest research advancements on circHIPK3 in NSCLC,aiming to promote precise diagnosis and treatment of lung cancer.

Circular RNAHIPK3Lung neoplasmsCompetitive endogenous RNABiomarkers

王宇恒、陈亮

展开 >

210000 南京,南京医科大学第一附属医院胸外科

环状RNA HIPK3 肺肿瘤 竞争性内源性RNA 生物标志物

2024

中国肺癌杂志
中国抗癌协会 中国防痨协会 天津医科大学总医院

中国肺癌杂志

CSTPCD北大核心
影响因子:1.397
ISSN:1009-3419
年,卷(期):2024.27(8)